Birdwatch Note
2024-10-12 08:07:45 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
À l’heure actuelle le paracetamol (molécule active du médicament) est déjà fabriqué à plus de 80% aux USe et en Inde, la vente d’opella n’est donc en rien un scandale https://www.europe1.fr/economie/medicaments-ou-en-est-la-production-de-paracetamol-en-france-4158838.amp
Written by 688F6C5DAE9798C7E8BE0885692374236632978CD6AB742F828AA930E7C3A1AB
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1844737168259912150
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1845013471923974286
- noteId - 1845013471923974286
- participantId -
- noteAuthorParticipantId - 688F6C5DAE9798C7E8BE0885692374236632978CD6AB742F828AA930E7C3A1AB
- createdAtMillis - 1728720465057
- tweetId - 1844737168259912150
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- À l’heure actuelle le paracetamol (molécule active du médicament) est déjà fabriqué à plus de 80% aux USe et en Inde, la vente d’opella n’est donc en rien un scandale https://www.europe1.fr/economie/medicaments-ou-en-est-la-production-de-paracetamol-en-france-4158838.amp
Note Ratings
| rated at | rated by | |
| 2024-10-12 13:07:37 -0500 | Rating Details | |
| 2024-10-12 06:08:58 -0500 | Rating Details | |
| 2024-10-12 05:31:43 -0500 | Rating Details | |
| 2024-10-12 04:20:23 -0500 | Rating Details | |
| 2024-10-12 06:13:31 -0500 | Rating Details | |
| 2024-10-12 05:40:22 -0500 | Rating Details | |
| 2024-10-12 05:14:27 -0500 | Rating Details | |
| 2024-10-12 04:26:52 -0500 | Rating Details | |
| 2024-10-12 03:38:46 -0500 | Rating Details | |
| 2024-10-12 06:47:56 -0500 | Rating Details | |
| 2024-10-12 06:02:42 -0500 | Rating Details | |
| 2024-10-12 05:32:36 -0500 | Rating Details | |
| 2024-10-12 13:02:12 -0500 | Rating Details | |
| 2024-10-12 05:38:50 -0500 | Rating Details | |
| 2024-10-12 05:06:53 -0500 | Rating Details | |
| 2024-10-12 10:57:58 -0500 | Rating Details | |
| 2024-10-12 10:44:48 -0500 | Rating Details | |
| 2024-10-12 09:26:46 -0500 | Rating Details | |
| 2024-10-12 08:21:14 -0500 | Rating Details | |
| 2024-10-12 07:53:51 -0500 | Rating Details | |
| 2024-10-12 07:36:14 -0500 | Rating Details | |
| 2024-10-12 05:58:07 -0500 | Rating Details | |
| 2024-10-12 05:27:25 -0500 | Rating Details | |
| 2024-10-12 03:25:47 -0500 | Rating Details | |
| 2024-10-12 03:12:17 -0500 | Rating Details |